【1】Mu A, McDonald D, Jarmusch AK, et al. Assessment of the microbiome during bacteriophage therapy in combination with systemic antibiotics to treat a case of staphylococcal device infection. Microbiome. 2021 Apr 14;9(1):92. doi: 10.1186/s40168-021-01026-9.
【2】Giulieri SG, Holmes NE, Stinear TP, Howden BP. Use of bacterial whole- genome sequencing to understand and improve the management of invasive Staphylococcus aureus infections. Expert Rev Anti Infect Ther. 2016; 14(11):1023–36. https://doi.org/10.1080/14787210.2016.1233815.
【3】World Health Organization. Antimicrobial Resistance: Global Report on Surveillance 2014. http://www.who.int/drugresistance/documents/surveilla ncereport/en/ Accessed on 22 July 2019.
【4】Schooley RT, Biswas B, Gill JJ, et al. Development and use of personalized bacteriophage-based therapeutic cocktails to treat a patient with a disseminated resistant Acinetobacter baumannii infection. Antimicrob. Agents Chemother. 2017;61(10):e00954–17. https://doi.org/10.1128/AAC. 00954-1.
【5】Aslam S, Lampley E, Wooten D, et al. Lessons learned from the first 10 consecutive cases of intravenous bacteriophage therapy to treat multidrug- resistant bacterial infections at a single center in the United States. Open Forum Infect Dis. 2020;7(9):ofaa389. https://doi.org/10.1093/ofid/ofaa389.
【6】Aslam S, Pretorius V, Lehman SM, Morales S, Schooley RT. Novel Bacteriophage therapy for treatment of left ventricular assist device infection. J Heart Lung Transplant. 2019;38(4):475–6. https://doi.org/10.1016/ j.healun.2019.01.001.
文獻下載鏈接：
https://pan.baidu.com/s/1Jr98pDMnvHqNNh8_WvUfXg
提取碼：dfjv
